Lonvita has acquired a 68% stake in Health Italia

December 2025 — The investment vehicle Lonvita S.p.A. has acquired a 68% stake in Health Italia S.p.A. as part of an entrepreneurial project promoted by Giovanni Giuliani and Stefano Pellegrino in the supplementary healthcare sector. The deal includes the launch of a mandatory public offer for the remaining shares of Health Italia, with the objective of delisting the company. Valued at approximately US$70 million, the transaction was structured as a club deal that secured control of Health Italia via Lonvita.

Clessidra Capital Credit SGR, through the Clessidra private debt fund, supported the promoters Giuliani and Pellegrino by providing both equity and mezzanine instruments. Under the new governance structure, Giuliani will assume the role of CEO, while Pellegrino will serve as chairman, guiding the company through its next phase of development.

Founded in 2001, Health Italia has established itself as a benchmark in the supplementary healthcare sector, offering mutualistic solutions, welfare services and telemedicine through a network of more than 8,000 affiliated facilities. The entrepreneurial project, led by Giuliani and Pellegrino, is designed to further enhance the company’s assets and leverage the expertise of Health Italia’s management team, strengthening the distribution platform and expanding the offering through targeted investments in marketing and technology.

Prior to the transaction, Health Italia was controlled by Sorgiva Holding, PFH, Mutua MBA and the founding shareholders, who together held an absolute majority, with the remaining shares owned by public market investors.

Our role in the transaction

Oaklins’ team in Italy acted as the financial advisor to Lonvita in its acquisition of Health Italia. In addition, Oaklins Italy’s parent company, Banca Akros, served as the intermediary responsible for coordinating the collection of acceptances for the mandatory public offer.